EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

EnhancerAtlas 2.0

Tag

Content

EnhancerAtlas ID

HS073-13382

Organism

Homo sapiens

Tissue/cell

GM19238

Coordinate

chr7:99787650-99788680

Target genes

Number: 33
Name	Ensembl ID

TRIM4	ENSG00000146833
GJC3	ENSG00000176402
ZKSCAN1	ENSG00000106261
ZSCAN21	ENSG00000166529
ZNF3	ENSG00000166526
COPS6	ENSG00000168090
AP4M1	ENSG00000221838
MCM7	ENSG00000166508
CNPY4	ENSG00000166997
TAF6	ENSG00000106290
MBLAC1	ENSG00000214309
C7orf59	ENSG00000188186
C7orf43	ENSG00000146826
GAL3ST4	ENSG00000197093
GPC2	ENSG00000213420
STAG3	ENSG00000066923
PVRIG	ENSG00000213413
GATS	ENSG00000239521
SPDYE3	ENSG00000214300
PILRB	ENSG00000121716
CTB	ENSG00000242294
PMS2P1	ENSG00000078319
PILRA	ENSG00000085514
MEPCE	ENSG00000146834
ZCWPW1	ENSG00000078487
RP11	ENSG00000240211
PPP1R35	ENSG00000160813
TSC22D4	ENSG00000166925
AGFG2	ENSG00000106351
LRCH4	ENSG00000077454
MOSPD3	ENSG00000106330
GNB2	ENSG00000172354
POP7	ENSG00000172336

TF binding sites/motifs

Number: 1

JASPAR ID

Coordinate

Motif Sequence

Strand

-Log10(p-value)

NFIL3

MA0025.1

chr7:99787687-99787698

TTATGTAACCT

6.14

dbSUPER

Number of super-enhancer constituents: 2
ID	Coordinate	Tissue/cell

SE_10301	chr7:99787212-99791483	CD19_Primary
SE_11379	chr7:99786621-99791186	CD20

HEDD

Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1
Chromosome	Start	End

chr7

99787862

99788148

GeneHancer

Number: 2
ID	Chromosome	Start	End

GH07I100189	chr7	99787474	99788297
GH07I100190	chr7	99788526	99791363

Enhancer Sequence

TTAAATTCTG TTGAATTTAG TCACTAGCTC CATAGCCTTA TGTAACCTCT CTTCAGTTTT 60
CTTTTCTTTA AAAAAAGGAA TAATCTCACC TTTTTGTGAA GAATAAATGA GATGAGTAAA 120
TTGCCTCGCT TGGCTCATAG TAGATACTTG TTTTGTTTCC TTTTAAACTT AAAGATGACC 180
ACTGGGGGGC ATAAGCCATA GCAAAATCTT TTACGCTGAT GAAATCTTTA ATCAGCTGGG 240
TCTGTCATAA GAGTAACACT ACTGGTGTTT TCTCCTCACT CTCTGTTAGT GTCTAAGACC 300
CCTCCTATGA GGTTGGCAGG ACTCACCATG TCTGACCATA TCATTTGGCT GTTTCTCTAG 360
CCCTCACAAA AGATCTCTTC CATTCTAAAT CACTAGAGAA GGAAACTTTC CACTTCCCTT 420
ATTCTCTTTT GTTATTTTGC ATTGTCAGGT TGATCTTAAA AGCTTGAATA TTAATCTATC 480
CCGGATTTTA AATTATGTAC ACTAGTGCGA ATCTTTTCTT TTCTTTTTCT TTTTTGGCTT 540
CTCTGGGCTC TTGCTTAATC AATTATCATT ATAATTCCCC CATTTTATCC TAAATTTCTT 600
CCTCCCCACT ATTTTCTTCT CTCCACTTAT AAATGTATAT AGGCTCTTGA ATCTTTATTT 660
CACTCTGCTC CTTTGTGAGT TACTCTTTTT TCCATCCTTC CTTTTAGGAT AGTATTTCCT 720
TACTTCCTTA ATGTCCAACT AACTGAATCC TTTTTGCTAC CTAGCTTATT TCCCCATTTT 780
CTTTGAAACT GTTCTTTCTA AACCAATGAC TTCCTAATTC CTAAAGCCAG TAGCCTTTTC 840
TCAGTCTCCC TTTCCCAAAT ATTTTACATA TTTGCTTTAC CTATTTTTGC TATTTTAGTG 900
TAAAATATGG ACATATAGGT ACTTCAGCCC TAAAGACTTA AGTATGTCCT GTCGAAAATG 960
ATATGTTGTT CTTACATAAT TGAAGAGGTG GGGCCTGTTG TCTTAAAGGA TGTTCCCTTT 1020
CTCCTTATAA 1030